These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
PROGAMING PLATFORMS CORP.
|
||
|
(Exact name of Registrant as specified in its charter)
|
||
|
Delaware
|
98-0663823
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
|
|
60 Mazeh Street, Apartment 12,
Tel Aviv, 65789, Israel
|
||
|
(Address of principal executive offices) (zip code)
|
||
|
+972-54-222-9702
|
||
|
(Registrant’s telephone number, including area code)
|
||
|
N/A
|
||
|
(Former name, former address and former fiscal year, if changed since last report)
|
||
|
Large accelerated filer
|
o |
Accelerated filer
|
o |
|
Non-accelerated filer
|
o |
Smaller reporting company
|
x |
|
(Do not check if a smaller reporting company)
|
|
Pg.
|
||
|
|
||
|
|
2
|
|
|
·
Balance Sheets
|
2
|
|
|
·
Statements of Operations
|
3
|
|
|
·
Statements of Cash Flows
|
4
|
|
|
·
Notes to Financial Statements
|
5
|
|
|
|
9
|
|
|
|
11
|
|
|
|
12
|
|
|
|
||
|
|
13
|
|
|
|
13
|
|
|
|
13
|
|
|
Item 6.
Exhibits
|
13
|
|
|
Signatures
|
14
|
|
March 31,
|
December 31,
|
|||||||
|
2012
|
2011
|
|||||||
|
(Unaudited)
|
(Audited)
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 74,379 | $ | 110,847 | ||||
|
Restricted cash
|
3,947 | 3,940 | ||||||
|
Prepaid expenses
|
17,490 | 229 | ||||||
|
Total current assets
|
95,816 | 115,016 | ||||||
|
Property and Equipment, net
|
724 | 801 | ||||||
|
Total assets
|
$ | 96,540 | $ | 115,817 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued liabilities
|
$ | 34,482 | $ | 24,640 | ||||
|
Related parties payable
|
35,303 | 33,000 | ||||||
|
Deferred revenues
|
5,800 | 5,800 | ||||||
|
Total current liabilities
|
75,585 | 63,440 | ||||||
|
Long-term deferred revenues
|
18,846 | 20,292 | ||||||
|
Commitments and Contingencies
|
||||||||
|
Stockholders' equity
|
||||||||
|
Common stock, par value $.0001 per share, 500,000,000 shares
|
||||||||
|
authorized; 50,455,000 and 50,400,000 shares issued and outstanding at March 31, 2012 and December 31 2011
|
510 | 504 | ||||||
|
Stock subscription receivable
|
( 300 | ) | ( 300 | ) | ||||
|
Additional paid in capital
|
152,126 | 133,882 | ||||||
|
(Deficit) accumulated during the development stage
|
(150,227 | ) | (102,001 | ) | ||||
|
Total stockholders' equity
|
2,109 | 32,085 | ||||||
|
Total liabilities and stockholders' equity
|
$ | 96,540 | $ | 115,817 | ||||
|
For the three
|
For the three
|
From May 26, 2010
|
||||||||||
|
months ended
|
months ended
|
date of inception to
|
||||||||||
|
March 31, 2012
|
March 31, 2011
|
March 31, 2012
|
||||||||||
|
Revenues, net
|
$ | 1,446 | $ | - | $ | 94,354 | ||||||
|
Expenses:
|
||||||||||||
|
Research and development
|
(20,340 | ) | (3,000 | ) | (87,466 | ) | ||||||
|
Marketing and general and administrative
|
(30,832 | ) | (17,681 | ) | (149,819 | ) | ||||||
|
Total operating expenses
|
(51,172 | ) | (20,681 | ) | (237,285 | ) | ||||||
|
(Loss) from operations
|
(49,726 | ) | (20,681 | ) | (142,931 | ) | ||||||
|
Financial income
|
1,500 | 242 | (7,296 | ) | ||||||||
|
Net (loss)
|
$ | (48,226 | ) | $ | (20,439 | ) | $ | (150,227 | ) | |||
|
(Loss) per common share - basic and diluted
|
$ | (0.00 | ) | ( 0.00 | ) | |||||||
|
Weighted average number of common shares outstanding
|
50,400,000 | 50,000,000 | ||||||||||
|
For the three
|
For the three
|
From May 26, 2010,
|
||||||||||
|
months ended
|
months ended
|
date of inception
|
||||||||||
|
March 31, 2012
|
March 31, 2011
|
through March 31, 2012
|
||||||||||
|
Operating Activities:
|
||||||||||||
|
Net (loss)
|
$ | (48,226 | ) | $ | (20,439 | ) | $ | (150,227 | ) | |||
|
Adjustments to reconcile net (loss) to net cash (used in)
|
||||||||||||
|
operating activities:
|
||||||||||||
|
Changes in net assets and liabilities-
|
||||||||||||
|
Increase in prepaid expenses
|
( 17,261 | ) | ( 165 | ) | ( 17,490 | ) | ||||||
|
Increase in accounts payable and other current liabilities
|
9,842 | 11,344 | 34,482 | |||||||||
|
Related parties payable
|
2,303 | - | 35,303 | |||||||||
|
(Decrease) increase in deferred revenue
|
( 1,446 | ) | - | 24,646 | ||||||||
|
Contribution of services from shareholder
|
- | - | 17,100 | |||||||||
|
Stock based compensation
|
18,250 | - | 18,250 | |||||||||
|
Depreciation
|
77 | - | 223 | |||||||||
|
Net cash (used in) operating activities
|
( 36,461 | ) | ( 9,260 | ) | (37,713 | ) | ||||||
|
Investing activities:
|
||||||||||||
|
Increase in restricted cash
|
( 7 | ) | - | (3,947 | ) | |||||||
|
Purchases of Property and Equipment
|
- | - | (947 | ) | ||||||||
|
Net cash (used in) investing activities
|
( 7 | ) | - | (4,894 | ) | |||||||
|
Financing activities:
|
||||||||||||
|
Proceeds from issuance of shares (net of issuance expenses)
|
- | - | 116,986 | |||||||||
|
Net cash provided by financing activities
|
- | - | 116,986 | |||||||||
|
(Decrease) increase in cash
and cash equivalents
|
(36,468 | ) | (9,260 | ) | 74,379 | |||||||
|
Cash
and cash equivalents
at beginning of period
|
110,847 | 68,868 | - | |||||||||
|
Cash
and cash equivalents
at end of period
|
$ | 74,379 | $ | 59,608 | $ | 74,379 | ||||||
|
Supplemental disclosure of cash flow information:
|
||||||||||||
|
Cash paid during the period for:
|
||||||||||||
|
Interest
|
$ | - | $ | - | $ | - | ||||||
|
Income taxes
|
$ | - | $ | - | $ | - | ||||||
|
%
|
|||||
|
Computers and electronic equipment
|
33
|
|
Exhibit No.
|
Description
|
|
3.1
|
Articles of Incorporation (Incorporated by reference from our Registration Statement on Form S-1 filed on October 19, 2010).
|
|
3.1.1
|
Certificate of Amendment of Certificate of Incorporation (Incorporated by reference from our Periodic Report on Form 8-K filed on March 1, 2012).
|
|
3.2
|
Bylaws (Incorporated by reference from our Registration Statement on Form S-1 filed on October 19, 2010).
|
|
4.1
|
Specimen ordinary share certificate (Incorporated by reference from our Registration Statement on Form S-1 filed on October 19, 2010).
|
|
31.1*
|
Section 302 Certification of the Sarbanes-Oxley Act of 2002 of Doron Uziel.
|
|
32.1*
|
Section 906 Certification of the Sarbanes-Oxley Act of 2002 of Doron Uziel.
|
|
/s/ Doron Uziel
Doron Uziel
Principal Executive Officer,
Chief Financial Officer, Treasurer and Secretary
(who also performs as Principal Financial Officer and Principal Accounting Officer)
May 14, 2012
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|